Information Library
Results for: Commercial Services - Product Development & Commercialization
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Quintiles Backs Change to Marketing Mix as NHS Reforms Take Hold
Press Release — READING, UK – 30 May, 2012 – Quintiles has released the first in a series of briefing papers looking at how market access strategies can
-
UK Market Access Insight Brief
White Paper — May 30, 2012
Insight Briefing series on Market Access in key European countries -
Accelerating Success in Oncology
Brochure — March 9, 2012
New Demands to Demonstrate Value Require New Strategy Proof of efficacy is no longer enough to ensure success in oncology. As the cost and complexity -
Reinventing Biopharma
White Paper — February 1, 2012
The biopharmaceutical industry today is facing a multifaceted “value challenge.” -
Harish Dave Discusses ASH 2011
Hear from the Experts — December 8, 2011
Harish Dave discusses the American Society of Hematology annual meeting. -
Multi-Channel Strategy
Brochure — November 9, 2011
Rethinking the Real Points of Power Today, pharmaceutical and biotech companies relying on a conventional communication strategy aimed squarely and exclusively at physicians find themselves -
Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.
Press Release — October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).
-
Quintiles Acquires VCG & Associates and VCG Bio
Press Release — October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.
-
An Integrated Approach to Biosimilar Development & Commercialization
White Paper — September 29, 2011
As the market for biosimilar products continues to grow, many biopharmaceutical companies trying to enter the space are struggling to overcome the unique challenges that developing such products presents. -
Quintiles Approach to "Real-World" Research helps Biopharma Customers Drive Competitive Advantage
Press Release — September 19, 2011 –A perfect storm of stakeholder demands, unprecedented data access, new data channels and technologies is driving a dramatic shift in research methodologies among biopharmaceutical companies, according to a new report from Quintiles.
